Which one of the following would you first need to determine is uniquely expressed in a tumor cell in order to change a “blocking” monoclonal antibody like Herceptin or Cetuximab into a chemotherapeutic “smart bomb” to target just that cell? A. An overexpressed tumor-specific transcription factor (e.g., c-myc). B. A tumor-specific […]